Prodotti competitors / Area Kite
Removal of orphan designation status for Glofitamab in Europe
Removal of orphan designation from the EU Community Register for Glofitamab indicated for Treatment of diffuse large B-cell lymphoma.
Source: https://ec.europa.eu/health/documents/community-register/html/o2497.htm#proc165911
Grazie per il tuo feedback!